The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial and Hurricane Katrina: Lessons for managing clinical trials during and after a natural disaster

被引:4
|
作者
McDuffie, Roberta
Summerson, John [2 ]
Reilly, Patricia
Blackwell, Caroline [2 ]
Goff, David [2 ]
Kimel, Angela R. [2 ]
Crago, Lenore [2 ]
Fonseca, Vivian [1 ]
机构
[1] Tulane Univ, Med Ctr, Dept Med & Pharmacol, New Orleans, LA 70112 USA
[2] Wake Forest Univ Hlth Sci, Winston Salem, NC USA
关键词
disaster; diabetes;
D O I
10.1016/j.cct.2008.05.006
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hurricane Katrina was one of the most catastrophic natural disasters to hit the United States. it had a major impact on health care in New Orleans, [A and the surrounding region, not only in relation to acute illness but also chronic disease. When Hurricane Katrina struck New Orleans on August 29, 2005. there were 193 participants being followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial at Tulane University Health Sciences Center. In the immediate aftermath of the storm, the Tulane University ACCORD Study site, in collaboration with the Study Coordinating Center and the Southeast Clinical Center Network office of the trial at Wake Forest University Health Sciences in North Carolina, took several actions in order to locate the participants, ensure their safety, and maintain the scientific integrity of the trial. We describe the actions taken and the relative success/failure of such actions. Published by Elsevier Inc.
引用
收藏
页码:756 / 761
页数:6
相关论文
共 50 条
  • [41] Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE)
    Chew, Emily Y.
    Ambrosius, Walter T.
    Howard, Letitia T.
    Greven, Craig M.
    Johnson, Samantha
    Danis, Ronald P.
    Davis, Matthew D.
    Genuth, Saul
    Domanski, Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A): : 103I - 111I
  • [42] Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial
    Shah, Hetal S.
    Gao, He
    Morieri, Mario Luca
    Skupien, Jan
    Marvel, Skylar
    Pare, Guillaume
    Mannino, Gaia C.
    Buranasupkajorn, Patinut
    Mendonca, Christine
    Hastings, Timothy
    Marcovina, Santica M.
    Sigal, Ronald J.
    Gerstein, Hertzel C.
    Wagner, Michael J.
    Motsinger-Reif, Alison A.
    Buse, John B.
    Kraft, Peter
    Mychaleckyj, Josyf C.
    Doria, Alessandro
    DIABETES CARE, 2016, 39 (11) : 1915 - 1924
  • [43] Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial
    Barzilay, Joshua I.
    Howard, Annie G.
    Evans, Gregory W.
    Fleg, Jerome L.
    Cohen, Robert M.
    Booth, Gillian L.
    Kimel, Angela R.
    Pedley, Carolyn F.
    Cushman, William C.
    DIABETES CARE, 2012, 35 (07) : 1401 - 1405
  • [44] Cost of Achieving A1C Treatment Goals in Patients with Type 2 Diabetes: Results from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Zhang, Ping
    Shao, Hui
    Bertoni, Alain
    Lovato, Laura
    Chen, Haiying
    DIABETES, 2020, 69
  • [45] Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Rationale and design
    Sullivan, Mark D.
    Anderson, Roger T.
    Aron, David
    Atkinson, Hal H.
    Bastien, Arnaud
    Chen, G. John
    Feeney, Patricia
    Gafni, Amiram
    Hwang, Wenke
    Katz, Lois A.
    Narayan, K. M. Venkat
    Nwachuku, Chuke
    O'Connor, Patrick J.
    Zhang, Ping
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12A): : 90I - 102I
  • [46] Visual acuity outcomes of cataract surgery in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study
    Lee, Debora Hana
    Agron, Elvira
    Keenan, Tiarnan D. L.
    Greven, Craig M.
    Danis, Ronald P.
    Lovato, James F.
    Ambrosius, Walter T.
    Chew, Emily Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [47] Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
    Chew, Emily Y.
    Lovato, James F.
    Davis, Matthew D.
    Gerstein, Hertzel C.
    Danis, Ronald P.
    Ismail-Beigi, Faramarz
    Genuth, Saul
    Greven, Craig M.
    Perdue, Letitia H.
    Cushman, William C.
    Elam, Marshall B.
    Bigger, J. Thomas
    Ginsberg, Henry N.
    Goff, David C., Jr.
    Ambrosius, Walter T.
    DIABETES CARE, 2016, 39 (07) : 1089 - 1100
  • [48] Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
    Huang, Chenxi
    Dhruva, Sanket S.
    Coppi, Andreas C.
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Nasir, Khurram
    Krumholz, Harlan M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (11):
  • [49] Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials
    Riddle, Matthew C.
    Karl, Diane M.
    DIABETES CARE, 2012, 35 (10) : 2100 - 2107
  • [50] The Cross-sectional and Longitudinal Associations of Diabetic Retinopathy With Cognitive Function and Brain MRI Findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Hugenschmidt, Christina E.
    Lovato, James F.
    Ambrosius, Walter T.
    Bryan, R. Nick
    Gerstein, Hertzel C.
    Horowitz, Karen R.
    Launer, Lenore J.
    Lazar, Ronald M.
    Murray, Anne M.
    Chew, Emily Y.
    Danis, Ronald P.
    Williamson, Jeff D.
    Miller, Michael E.
    Ding, Jingzhong
    DIABETES CARE, 2014, 37 (12) : 3244 - 3252